Researchers at cancer centers in Canada, the United Kingdom and the U.S., including the Miller School of Medicine’s Sylvester Comprehensive Cancer Center, have developed a breakthrough diagnostic test to identify which men are most likely to have a recurrence of prostate cancer after localized treatment with surgery or radiotherapy. Their findings have been published in the November issue of Lancet Oncology.
Stratifying patients based on their relative risk of recurrence has long been an inexact science. Between 30 percent and 50 percent will have their cancer return due to undertreatment of aggressive disease that has already spread outside the prostate gland but was not found during their initial procedure. At the same time, men who are defined as low to intermediate risk are often overtreated because current tests are unable to identify those who have more aggressive disease. This can cause unnecessary treatment leading to toxicity and unneeded expense.
W. Dalton Dietrich, Ph.D., Scientific Director of The Miami Project to Cure Paralysis and Kinetic Concepts Distinguished Chair in Neurosurgery, and Coleen Atkins, Ph.D., assistant professor of neurological surgery, have been awarded a $2 million, five-year grant by the National Institutes of Health to further develop a promising compound that could potentially help millions suffering from brain injury.
Remembered for his bright intellect and expanding the University of Miami Miller School of Medicine’s scientific footprint, Werner Loewenstein, Ph.D., professor and former Chair of the Department of Physiology and Biophysics, passed away on November 17.
Claes Wahlestedt, M.D., Ph.D., Leonard M. Miller professor and vice chair of psychiatry and behavioral sciences and Associate Dean for Therapeutic Innovation, is one of 15 researchers nationally to receive a Distinguished Investigator Grant from the Brain and Behavior Research Foundation.
University of Miami Miller School of Medicine student Johanna Kreafle recently won an American Medical Association poster competition for a novel program she co-founded that educates patients about their health in the waiting room as part of their doctor visits.
A team of international researchers, led by investigators at the Miller School of Medicine’s Department of Medicine and Diabetes Research Institute (DRI), has found that young capillary vessels can rejuvenate aged pancreatic islets. The study finding is significant because it suggests that targeting inflammation and fibrosis in the small blood vessels of the islet may offer new treatment options for type 2 diabetes.